Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114882) titled 'Clinical study on half of the effective dose of remifentanil used for gastroscopy under deep sedation in elderly patients' on Dec. 18, 2025.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
Condition:
None
Intervention:
Refentanil group:Refentanil
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-09-01
Target Sample Size: Refentanil group:30;Remazolam group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=289031
Published by HT ...